COVID-19: Vaccines and Therapeutics
Medicare will nearly double what it pays to administer COVID-19 vaccines to about $40 per dose to better reflect the costs involved and help providers vaccinate more Americans, the Centers for Medicare & Medicaid Services announced today.
As urged by the AHA, the Centers for Medicare & Medicaid Services (CMS) today announced it is increasing the Medicare payment rates for COVID-19 vaccine administration.
President Biden directed states, tribes and territories to make all adults eligible for COVID-19 vaccination by May 1.
President Biden, citing the need for maximum flexibility in the nation’s vaccination program, announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.
With the emergency use authorization for a third COVID-19 vaccine, progress is being made in efforts to vaccinate the public. Still, challenges remain, particularly with communication around supplies and eligibility.
FEMA has established the Civil Rights Advisory Group as part of the agency’s commitment to the COVID-19 vaccination mission amid the ongoing battle against the pandemic.
Cities, counties and other local governments may apply through April 20 for grants to work with community-based organizations to encourage COVID-19 safety and vaccination in vulnerable and underserved populations.
The Centers for Disease Control and Prevention released interim guidelines for fully vaccinated individuals’ social practices. CDC said that those who are fully vaccinated — whether the two doses required by the Pfizer and Moderna vaccines, or the single Johnson & Johnson dose — may eschew…
The Senate today voted 50-49 to approve a modified version of the American Rescue Plan Act of 2021, a $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. It is our understanding there may be some additional text changes to the bill…
A research letter published in the New England Journal of Medicine looks at delayed injection-site skin reactions to the Moderna COVID-19 vaccine four to 11 days after 12 people received the first dose.